Skip to main content
. 2021 Oct 11;62(12):3005–3015. doi: 10.1111/epi.17091

FIGURE 4.

FIGURE 4

One hundred percent seizure reduction among (A) all patients (n = 240) and (B) patients continuing cenobamate at data cutoff (n = 177)